The New Standing Guideline Committee Policy of the American Stroke Association Stroke Council
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Seropositivity to Chlamydia pneumoniae Is Associated With Risk of First Ischemic Stroke
The Stroke-Prone State: Rapid Assessment of Transient Ischemic Attacks

Retinal Progenitor Cells — Timing Is Everything
Stress, Aging, and Neurodegenerative Disease

The Stroke-Prone State: Rapid Assessment of Transient Ischemic Attacks
The End of an Era in Otitis Research
The New Standing Guideline Committee Policy of the American Stroke Association Stroke Council

Radiotherapy for Glioblastoma in the Elderly
Ranibizumab for Neovascular Age-Related Macular Degeneration
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

Seropositivity to Chlamydia pneumoniae Is Associated With Risk of First Ischemic Stroke
Stroke Onset Time Using Sodium MRI in Rat Focal Cerebral Ischemia

Reconstructing Lives — A Tale of Two Soldiers
The Price of Sight — Ranibizumab, Bevacizumab, and the Treatment of Macular Degeneration
SERPINA3 Polymorphism Is Not Associated With Primary Intracerebral Hemorrhage in a Polish Population
Ten-Year Incidence of Retinal Emboli in an Older Population
The Risks and Safety of Clopidogrel in Pediatric Arterial Ischemic Stroke